Latest Breaking News On - Aino annual report - Page 2 : comparemela.com

Ainos, Inc : Ainos Announces Successful Manufacturing of VELDONA GMP Clinical Batch by Swiss Pharmaceutical

Ainos, Inc : Ainos Announces Successful Manufacturing of VELDONA GMP Clinical Batch by Swiss Pharmaceutical
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Switzerland generalSan diegoUnited statesEddy tsaiRobin yangStefan klotterAlbert yuSwiss pharmaceutical co ltdAinos inc viewDrug administrationClinical batch of the companyExchange commissionAinos incSwiss pharmaceutical co ltd taiwanDrug developmentSubsequent phase involves completion

Ainos, Inc : Ainos Announces Positive Data Reported from its Clinical Studies for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA

Ainos, Inc : Ainos Announces Positive Data Reported from its Clinical Studies for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSan diegoRheinland pfalzEddy tsaiRobin yangAinos incExchange commissionAinos inc viewDrug administrationUnited states foodChief executive officerOrphan drug designationDrug designationAinos floraSecurities litigation reform actNasdaq capital market

Ainos Reports Third Quarter 2023 Financial Results

Ainos Reports Third Quarter 2023 Financial Results
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesSan diegoEddy tsaiRobin yangAinos incExchange commissionDrug administrationLind global fundDrug designation for the companyProduct cycle transition approachesProduct line expectedEgain momentumChief executive officerAinos floraLin sung

Ainos, Inc : Ainos Reports Third Quarter 2023 Financial Results

Ainos, Inc : Ainos Reports Third Quarter 2023 Financial Results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesNew yorkSan diegoRobin yangEddy tsaiDrug designation for the companyDrug administrationAinos incLind global fundExchange commissionProduct cycle transition approachesProduct line expectedEgain momentumChief executive officerAinos floraLin sung

Ainos Reports Third Quarter 2023 Financial Results - Ainos (NASDAQ:AIMD), Ainos (NASDAQ:AIMDW)

Product Cycle Transition Approaches its Final StagesNew Product Line Expected to Gain Momentum in the Fourth QuarterSAN DIEGO, CA / ACCESSWIRE / November 9, 2023 / Ainos, Inc. (NASDAQ:AIMD, AIMDW)) ("Ainos", or

New yorkUnited statesSan diegoEddy tsaiRobin yangExchange commissionDrug administrationAinos incLind global fundDrug designation for the companyCycle transition approachesProduct line expectedEgain momentumChief executive officerAinos floraLin sung